A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML. Issue 13 (10th November 2022)

Record Type:
Journal Article
Title:
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML. Issue 13 (10th November 2022)
Main Title:
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML
Authors:
Lontos, Konstantinos
Tsagianni, Anastasia
Agha, Mounzer
Raptis, Anastasios
Hou, Jing-Zhou
Farah, Rafic
Redner, Robert L.
Im, Annie
Dorritie, Kathleen A.
Sehgal, Alison
Rossetti, James
Aggarwal, Nidhi
Saul, Melissa
Gooding, William
Boyiadzis, Michael
Abstract:
Is Part Of:
Leukemia & lymphoma. Volume 63:Issue 13(2022)
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 13(2022)
Issue Display:
Volume 63, Issue 13 (2022)
Year:
2022
Volume:
63
Issue:
13
Issue Sort Value:
2022-0063-0013-0000
Page Start:
3257
Page End:
3260
Publication Date:
2022-11-10
Subjects:
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:
http://informahealthcare.com ↗
DOI:
10.1080/10428194.2022.2118532 ↗
Languages:
English
ISSNs:
1042-8194
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
24705.xml